Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Fluoxetine's effectiveness as an antidepressant in mice depends on a specific protein activity and a 5-minute pretest.

PRP is more effective than triamcinolone for treating alopecia areata.

A new method accurately detects illegal JAK inhibitors in hair loss cosmetics.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Finasteride reduces movement issues in Parkinson's disease rats.

Botulinum Toxin Type A effectively treats various conditions with high patient satisfaction and minimal side effects.

New partnerships, clinical trials, and drug approvals marked progress in therapeutic delivery in July 2018.

New compounds with carborane showed anti-androgen effects similar to flutamide.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

Blocking mTORC1 reduces skin tumor growth in mice.

KATP channels may help reduce itching in liver disease.

Trilostane may help delay epilepsy development by increasing certain brain chemicals.

Epristeride's metabolism involves key metabolites and proteins, affecting its use in doping tests.

Triamcinolone acetonide is slightly more effective than betamethasone for hair regrowth in localized alopecia areata.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Injecting triamcinolone into the eyebrow area may help eyelash regrowth in alopecia areata patients.

Higher CSF 5-HIAA levels may predict better response to serotonin re-uptake inhibitors in trichotillomania.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Nano-PROTACs could improve drug targeting and delivery by using nanotechnology.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

TRPV channels are important in osteoarthritis and could be key to new treatments.

TYK2 inhibitors show promise for treating cancer and autoimmune disorders.

PRMT5 inhibitors effectively fight adenoid cystic carcinoma in salivary glands.

Tridax procumbens extracts may help treat cancer due to their strong anticancer and antioxidant properties.

ETC-159 was safe up to 30 mg, but no tumor shrinkage was seen.